Pranatchareeya Chankhamjon

This study identifies disease-associated small molecules from the gut microbiome of IBD patients using metagenomic analysis and synthetic biology.

The paper systematically maps drug metabolism by the human gut microbiome, showing 13% of 575 drugs are metabolized by a single microbiome sample.